Co-founder Shailesh Kumar Davey will step into the role of Group CEO, succeeding Sridhar Vembu, who will now serve as Chief Scientist. Sridhar Vembu made the announcement via a post on social ...
CHENNAI: Sridhar Vembu has stepped down as the chief executive of Zoho Corp to focus more on the research and development of artificial intelligence products. Vembu would take up a new role as the ...
Sridhar Vembu, the founder and long-time chief executive officer of Zoho Corporation, has stepped down as CEO. He will now serve as the company’s chief scientist, focusing on research and ...
Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options begin trading this week, for the March 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up ...
Zoho co-founder Sridhar Vembu reignited the debate over India’s traditional knowledge systems, asserting that dismissing them outright reflects arrogance, not scientific rigor. In a post on ...
Dr Cyriac Abby Philips, a renowned hepatologist often referred to as 'The Liver Doc,' recently slammed Sridhar Vembu, co-founder and CEO of Zoho, for endorsing the views of IIT Madras Director Prof.
Liver specialist and clinician-scientist Dr Cyriac Abby Philips, popularly known as ‘The Liver Doctor’ on social media, slammed Zoho co-founder and CEO Sridhar Vembu for supporting IIT Madras ...
Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...
Zoho CEO Sridhar Vembu has backed IIT Madras director V Kamakoti in the cow urine controversy, claiming that modern science is waking up to its benefits. Zoho CEO Sridhar Vembu has backed IIT ...
Zoho CEO Sridhar Vembu backs IIT Madras Director Prof. V Kamakoti's claims on the medicinal properties of cow urine or gomutra. In a post on the social media platform X, Vembu wrote, "This nation ...
SAN FRAN­CIS­CO — Just over 20 years ago, the peo­ple of Cal­i­for­nia vot­ed to spend bil­lions of dol­lars on an ex­cit­ing new idea to re­make med­i­cine … ...